logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > China Stock

GMTEight List of A-share restricted sales and lifting restrictions | February 4th

date
09:00 04/02/2026
avatar
GMT Eight
I am currently studying for my final exams.
On February 4, a total of 1 listed company had its restricted shares lifted, with a total market value of approximately 3.756 billion yuan. The specific details of the restricted shares released today are as follows: Stock Abbreviation, Stock Code, Type of Restricted Shares, Number of Shares Unlocked China Micro Semicon (Shenzhen), 688380, 2.31 billion
Related Articles
HK Stock Market Move | ASCENTAGE-B(06855) increased by more than 3%. BTK degrader class 1 new drug APG-3288 tablets approved for clinical use.
CICC: Raised target price of EAST BUY (01797) to HK$30, Maintained "Outperform" rating.
China Stock
China Securities Co., Ltd: This round of deposits moving towards standardized capital market tools, residents' wealth allocation moving towards diversified investment portfolios.
HK Stock Market Move | ASCENTAGE-B(06855) increased by more than 3%. BTK degrader class 1 new drug APG-3288 tablets approved for clinical use.
CICC: Raised target price of EAST BUY (01797) to HK$30, Maintained "Outperform" rating.
China Securities Co., Ltd: This round of deposits moving towards standardized capital market tools, residents' wealth allocation moving towards diversified investment portfolios.
China Stock
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
icon
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
icon
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
icon
30/01/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.